Myasthenic crisis: A retrospective study

Neurology India

Volumn 52, Issue 4, 2004, Pages 453-456

  Panda, S ^a   Goyal, Vinay ^a   Behari, M ^a   Singh, S ^a   Srivastava, T ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Myasthenia gravis; Myasthenic crisis; Thymoma

Indexed keywords

CHOLINESTERASE INHIBITOR; IMMUNOGLOBULIN; STEROID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DRUG WITHDRAWAL; FEMALE; HUMAN; INDIA; MALE; MORTALITY; MYASTHENIA GRAVIS; MYASTHENIC CRISIS; PLASMAPHERESIS; RETROSPECTIVE STUDY; THYMECTOMY; THYMOMA; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; INDIA; INTENSIVE CARE; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 12144263781     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Phillips LH, Tomer JC, Anderson MS, Cox GM. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992;42:1888-93.
2. Treves TA, Rocca WA, Meneghini F. Epidemiology of myasthenia gravis. In: Anderson DW, Schoenberg DG, editors. Neuroepidemiology. A tribute to Bruce Shoenberg. Boston: CRC Press; 1991. p. 297.
3. Ahurja GK, Mohandas S, Behari M. Myasthenia gravis: experienee with 70 patients. Neurol Ind 1983;31:15-23.
4. Gracey DR, Dievertie MB, Howard FM. Mechanical ventilation for respiratory failure in myasthenia gravis. Mayo Clin Proc 1983;58:597-602.
5. Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis crisis and death. Ann NY Acad Sci 1981;377:670-7.
6. Perlo VP, Poskanzer DC, Schwab RS, Viets HR, Osserman KE, Genkins G. Myasthenia gravis: Evaluation of treatment in 1355 patients. Neurology 1966;16:431-9.
7. Aggarwal AN, Gupta D, Behera D, Prabakar S, Jindal SK. Intensive respiratory care in patients with myasthenic crisis. Neurol India 2002;50:348-51.
8. Mayer SA. Intensive care of the myasthenic patient. Neurology 1997;48: S70-5.
9. Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, et al. Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation. Neurology 1997;48:1253-60.
10. Werueck LC, Scola RH, Germiniani FMB, Comerlato EA, Cunha FMB. Myasthenic crisis. Report of 24 cases. Arq Neuropsiquiatr 2002;60:519-24.
11. Fergusson IT, Murphy RP, Lascelles RG. Ventilatory failure in myasthenia gravis. J Neurol Neurosurg Psychiatry 1982;45:217-22.
12. Sellman MS, Mayer RF. Treatment of myasthenic crisis in late life. South Med J 1985;78:1208-10.
13. Mehra NK, Ahuja GK, Taneja V, Vaidya, MC. HLA antigens and myasthenia gravis in north India. J Neurol Neurosurg Psychiatry 1983;46:361-4.
14. Berrouschot J, Baumann I, Kalischewski P, Sterker M, Schneider D. Therapy of myasthenic crisis. Crit Care Med 1997;25:1228-35.
15. Oosterhius HJ. The natural course of myasthenia gravis: A long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-7.
16. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 1987;505:472-99.
17. Varelas PN, Chua HC, Natterman J, Barmadia L, Zimmerman P, Yahia A, et al. Ventilatory care in myasthenia gravis crisis: Assessing the baseline adverse event rate. Crit Care Med 2002;30:2663-8.
18. Selecky PA, Ziment I. Prolonged respiratory support for the treatment of intractable myasthenia gravis. Chest 1974;65:207-9.
19. Howard JF. Treatment of myasthemia gravis with plasma exchange. Semin Neurol l982;2:273-9.
20. Jaretski III A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB. Task force of medical scientific advisory board of the myasthenia gravis foundation of America. Neurology. 2000;55:16-23.